Hirsch R E, Lin M J, Nagel R L
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
J Biol Chem. 1988 Apr 25;263(12):5936-9.
We have reported that circulating CC erythrocytes containing HbO2 C crystals exhibit little or no Hb F suggesting that Hb F may inhibit the crystallization of Hb C. We report now that Hb F inhibits in vitro crystallization of HbO2 and HbCO C when compared to the effect of Hb A in a wide range of mixture proportions. For example, while HbCO C solutions form tetragonal C crystals within 25 min, no crystals form within 2 h with 30% Hb F, whereas 550 crystals/mm3 form with 30% Hb A. Furthermore, an increase in the percent of Hb A is correlated with a greater number of orthorhombic crystal formation rather than the tetragonal morphology observed with 100% Hb C. We also report that Hb A2 (containing delta chains that exhibit 10 sequence differences with beta chains) and Hb Lepore Boston-Washington (a fusion mutant of delta and beta chains that contains only six of these differences) both inhibit Hb C crystallization. By comparing the sequences of the three inhibitory hemoglobins, we conclude that position Gln-87 in the gamma chains is, at least partially, the cause of the inhibitory effect of Hb F on the crystallization of Hb C.
我们曾报道,含有HbO₂ C晶体的循环CC红细胞几乎不显示Hb F或完全不显示Hb F,这表明Hb F可能抑制Hb C的结晶。我们现在报道,与Hb A在广泛混合比例下的作用相比,Hb F在体外抑制HbO₂和HbCO C的结晶。例如,虽然HbCO C溶液在25分钟内形成四方C晶体,但在含有30% Hb F的情况下,2小时内无晶体形成,而含有30% Hb A时每立方毫米形成550个晶体。此外,Hb A百分比的增加与更多正交晶体的形成相关,而不是与100% Hb C时观察到的四方形态相关。我们还报道,Hb A₂(含有与β链有10个序列差异的δ链)和Hb Lepore Boston-Washington(δ链和β链的融合突变体,仅含有其中6个差异)均抑制Hb C结晶。通过比较三种抑制性血红蛋白的序列,我们得出结论,γ链中的第87位谷氨酰胺至少部分是Hb F对Hb C结晶产生抑制作用的原因。